{"id":17023,"date":"2020-10-23T07:42:22","date_gmt":"2020-10-23T11:42:22","guid":{"rendered":"https:\/\/medicarereport.org\/?p=17023"},"modified":"2020-10-23T07:42:22","modified_gmt":"2020-10-23T11:42:22","slug":"remdesivir-becomes-first-fda-approved-covid-19-treatment","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=17023","title":{"rendered":"Remdesivir becomes first FDA-approved COVID-19 treatment"},"content":{"rendered":"<p>(By\u00a0Katie Adams for <em>Becker&#8217;s Hospital Review<\/em>)<\/p>\n<p>The FDA on Oct. 22\u00a0granted approval\u00a0to remdesivir, which Gilead sells under the brand name Veklury, as a COVID-19 treatment for hospitalized patients aged 12 years and older.\u00a0 Continue reading article <a href=\"https:\/\/www.beckershospitalreview.com\/pharmacy\/remdesivir-becomes-first-fda-approved-covid-19-treatment.html\">here&#8230;<\/a><\/p>\n<p><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/08\/FDA-logo3.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-7883\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/08\/FDA-logo3.jpg\" alt=\"\" width=\"179\" height=\"181\" \/><\/a><\/p>\n<pre><strong>Notice:<\/strong> The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org<\/pre>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>(By\u00a0Katie Adams for Becker&#8217;s Hospital Review) The FDA on Oct. 22\u00a0granted approval\u00a0to remdesivir, which Gilead sells under the brand name<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[17,31,15],"tags":[],"class_list":["post-17023","post","type-post","status-publish","format-standard","hentry","category-emerging-health-issues","category-fda","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/17023","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=17023"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/17023\/revisions"}],"predecessor-version":[{"id":17024,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/17023\/revisions\/17024"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=17023"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=17023"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=17023"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}